If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Related content
Volume 4, Number 6, June 2006

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content A tale of two societies
pp. 1173-1174(2)
Authors: MEDCALF, R. L.; MANNUCCI, P. M.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms
pp. 1197-1205(9)
Authors: WATKINS, N. A.; O'CONNOR, M. N.; RANKIN, A.; JENNINGS, N.; WILSON, E.; HARMER, I. J.; DAVIES, L.; SMETHURST, P. A.; DUDBRIDGE, F.; FARNDALE, R. W.; OUWEHAND, W. H.

Favourites:Add to Favourites

Free Content D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism
pp. 1208-1214(7)
Authors: SHRIVASTAVA, S.; RIDKER, P. M.; GLYNN, R. J.; GOLDHABER, S. Z.; MOLL, S.; BOUNAMEAUX, H.; BAUER, K. A.; KESSLER, C. M.; CUSHMAN, M.

Favourites:Add to Favourites

Free Content Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model
pp. 1218-1225(8)
Authors: McCORMACK, W. M.; SEILER, M. P.; BERTIN, T. K.; UBHAYAKAR, K.; PALMER, D. J.; NG, P.; NICHOLS, T. C.; LEE, B.

Favourites:Add to Favourites

Free Content Parachutes and prophylaxis: they both work!
pp. 1226-1227(2)
Author: WHITE, G. C.

Favourites:Add to Favourites

Free Content Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study
pp. 1228-1236(9)
Authors: FELDMAN, B. M.; PAI, M.; RIVARD, G. E.; ISRAELS, S.; POON, M.-C.; DEMERS, C.; ROBINSON, S.; LUKE, K.-H.; WU, J. K. M.; GILL, K.; LILLICRAP, D.; BABYN, P.; MCLIMONT, M.; BLANCHETTE, V. S.

Favourites:Add to Favourites

Free Content Screening for children from families with Rendu–Osler–Weber disease: from geneticist to clinician
pp. 1237-1245(9)
Authors: GIORDANO, P.; NIGRO, A.; LENATO, G. M.; GUANTI, G.; SUPPRESSA, P.; LASTELLA, P.; DE MATTIA, D.; SABBÀ, C.

Favourites:Add to Favourites

Free Content Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry
pp. 1246-1252(7)
Authors: SPYROPOULOS, A. C.; TURPIE, A. G. G.; DUNN, A. S.; SPANDORFER, J.; DOUKETIS, J.; JACOBSON, A.; FROST, F. J.

Favourites:Add to Favourites

Free Content Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis
pp. 1253-1258(6)
Authors: WADA, H.; KOBAYASHI, T.; ABE, Y.; HATADA, T.; YAMADA, N.; SUDO, A.; UCHIDA, A.; NOBORI, T.

Favourites:Add to Favourites

Free Content Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study
pp. 1259-1265(7)
Authors: CANONICO, M.; OGER, E.; CONARD, J.; MEYER, G.; LÉVESQUE, H.; TRILLOT, N.; BARRELLIER, M. T.; WAHL, D.; EMMERICH, J.; SCARABIN, P. Y.

Favourites:Add to Favourites

Free Content Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil
pp. 1266-1270(5)
Authors: DEHEINZELIN, D.; BRAGA, A. L.; MARTINS, L. C.; MARTINS, M. A.; HERNANDEZ, A.; YOSHIDA, W. B.; MAFFEI, F.; MONACHINI, M.; CALDERARO, D.; CAMPOS, W.; SGUIZZATTO, G. T.; CARAMELLI, B.

Favourites:Add to Favourites

Free Content Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
pp. 1271-1278(8)
Authors: OHMORI, T.; YATOMI, Y.; NONAKA, T.; KOBAYASHI, Y.; MADOIWA, S.; MIMURO, J.; OZAKI, Y.; SAKATA, Y.

Favourites:Add to Favourites

Free Content Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study
pp. 1279-1287(9)
Authors: REINER, A. P.; CARTY, C. L.; CARLSON, C. S.; WAN, J. Y.; RIEDER, M. J.; SMITH, J. D.; RICE, K.; FORNAGE, M.; JAQUISH, C. E.; WILLIAMS, O. D.; TRACY, R. P.; LEWIS, C. E.; SISCOVICK, D. S.; BOERWINKLE, E.; NICKERSON, D. A.

Favourites:Add to Favourites

Free Content Plasminogen and plasmin activity in patients with coronary artery disease
pp. 1288-1295(8)
Authors: DRINANE, M. C.; SHERMAN, J. A.; HALL, A. E.; SIMONS, M.; MULLIGAN-KEHOE, M. J.

Favourites:Add to Favourites

Free Content Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome
pp. 1296-1302(7)
Authors: SIMAK, J.; GELDERMAN, M. P.; YU, H.; WRIGHT, V.; BAIRD, A. E.

Favourites:Add to Favourites

Free Content A genome-wide linkage scan for homocysteine levels suggests three regions of interest
pp. 1303-1307(5)
Authors: VERMEULEN, S. H. H. M.; VAN DER VLEUTEN, G. M.; DE GRAAF, J.; HERMUS, A. R.; BLOM, H. J.; STALENHOEF, A. F. H.; DEN HEIJER, M.

Favourites:Add to Favourites

Free Content Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII
pp. 1308-1314(7)
Authors: PINOTTI, M.; RIZZOTTO, L.; PINTON, P.; FERRARESI, P.; CHUANSUMRIT, A.; CHAROENKWAN, P.; MARCHETTI, G.; RIZZUTO, R.; MARIANI, G.; BERNARDI, F.

Favourites:Add to Favourites

Free Content Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants
pp. 1315-1322(8)
Authors: GALE, A. J.; RADTKE, K.-P.; CUNNINGHAM, M. A.; CHAMBERLAIN, D.; PELLEQUER, J.-L.; GRIFFIN, J. H.

Favourites:Add to Favourites

Free Content Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation
pp. 1323-1330(8)
Authors: MAUGERI, N.; BRAMBILLA, M.; CAMERA, M.; CARBONE, A.; TREMOLI, E.; DONATI, M. B.; DE GAETANO, G.; CERLETTI, C.

Favourites:Add to Favourites

Free Content The limits of simulation of the clotting system
pp. 1331-1338(8)
Authors: WAGENVOORD, R.; HEMKER, P. W.; HEMKER, H. C.

Favourites:Add to Favourites

Free Content International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain
pp. 1339-1345(7)
Authors: CHANTARANGKUL, V.; VAN DEN BESSELAAR, A. M. H. P.; WITTEVEEN, E.; TRIPODI, A.

Favourites:Add to Favourites

Free Content Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation
pp. 1354-1360(7)
Authors: SUZUKI, H.; SHIMA, M.; NOGAMI, K.; SAKURAI, Y.; NISHIYA, K.; SAENKO, E. L.; TANAKA, I.; YOSHIOKA, A.

Favourites:Add to Favourites

Free Content von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectively
pp. 1367-1378(12)
Authors: MCCARTY, O. J. T.; CALAMINUS, S. D. J.; BERNDT, M. C.; MACHESKY, L. M.; WATSON, S. P.

Favourites:Add to Favourites

Free Content Critical role of ADP interaction with P2Y12 receptor in the maintenance of αIIbβ3 activation: association with Rap1B activation
pp. 1379-1387(9)
Authors: KAMAE, T.; SHIRAGA, M.; KASHIWAGI, H.; KATO, H.; TADOKORO, S.; KURATA, Y.; TOMIYAMA, Y.; KANAKURA, Y.

Favourites:Add to Favourites

Free Content Platelet septin complexes form rings and associate with the microtubular network
pp. 1388-1395(8)
Authors: MARTÍNEZ, C.; CORRAL, J.; DENT, J. A.; SESMA, L.; VICENTE, V.; WARE, J.

Favourites:Add to Favourites

Free Content Human endothelial cells synthesize and release ADAMTS-13
pp. 1396-1404(9)
Authors: TURNER, N.; NOLASCO, L.; TAO, Z.; DONG, J.-F.; MOAKE, J.

Favourites:Add to Favourites

Free Content Patterns of changes of anti-ADAMTS13 after plasma exchange
pp. 1405-1406(2)
Authors: MANNUCCI, P. M.; BÖHM, M.; SCHARRER, I.; SCHEIFLINGER, F.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Factor Xa protects cultured hippocampal neurons from glutamate toxicity
pp. 1409-1410(2)
Authors: STRUKOVA, S.; GORBACHEVA, L.; STOROZHEVYKH, T.; PINELIS, V.; SMIRNOV, M.

Favourites:Add to Favourites

Free Content Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study
pp. 1411-1413(3)
Authors: ETTEMA, H. B.; HOPPENER, M. R.; VEEGER, N. J. G. M.; BÜLLER, H. R.; VAN DER MEER, J.

Favourites:Add to Favourites

Free Content β-Thalassemia intermedia and pregnancy: should we anticoagulate?
pp. 1413-1414(2)
Authors: NASSAR, A. H.; USTA, I. M.; TAHER, A. M.

Favourites:Add to Favourites

Free Content Regulation of endogenous tissue-type plasminogen activator expression is modulated by the −7351C>T enhancer polymorphism
pp. 1414-1418(5)
Authors: TjÄRNLUND-WOLF, A.; OLSSON, L.; MEDCALF, R. L.; JERN, C.

Favourites:Add to Favourites

Free Content The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment
pp. 1418-1420(3)
Authors: GARCIA, A. A.; VAN DER HEIJDEN, J. F.; MEIJERS, J. C. M.; ROSENDAAL, F. R.; REITSMA, P. H.

Favourites:Add to Favourites

Free Content Extra-virgin vs. refined olive oil on postprandial hemostatic markers in healthy subjects
pp. 1421-1422(2)
Authors: PACHECO, Y. M.; LÓPEZ, S.; BERMÚDEZ, B.; ABIA, R.; MURIANA, F. J. G.

Favourites:Add to Favourites

Free Content The impact of simvastatin on warfarin disposition and dose requirements
pp. 1422-1424(3)
Authors: SCONCE, E. A.; KHAN, T. I.; DALY, A. K.; WYNNE, H. A.; KAMALI, F.

Favourites:Add to Favourites

Free Content Can the PFA-100® be modified to detect P2Y12 inhibition?
pp. 1424-1426(3)
Authors: PIDCOCK, M.; HARRISON, P.

Favourites:Add to Favourites

Free Content More on: platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function
pp. 1426-1427(2)
Authors: KOSCIELNY, J.; KIESEWETTER, H.; VON TEMPELHOFF, G.-F.

Favourites:Add to Favourites

Free Content Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal
pp. 1432-1432(1)
Authors: HAYWARD, C. P. M.; HARRISON, P.; CATTANEO, M.; ORTEL, T. L.; RAO, A. K.

Favourites:Add to Favourites

Free Content Platelet function analyzer (PFA)-100®closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal
pp. 1433-1434(2)
Authors: HAYWARD, C. P. M.; HARRISON, P.; CATTANEO, M.; ORTEL, T. L.; RAO, A. K.

Favourites:Add to Favourites

Free Content Talking about…
pp. 1438-1440(3)
Authors: BRUTTOMESSO, G.; MIGLINO, N.

Favourites:Add to Favourites

Free Content Announcements
pp. 1441-1441(1)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more